Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
Yoshio Sumida, Masashi Yoneda, Yuya Seko, et al.
Diagnostics (2020) Vol. 10, Iss. 8, pp. 579-579
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma
Hira Hanif, Mukarram Jamat Ali, Ammu Susheela, et al.
World Journal of Gastroenterology (2022) Vol. 28, Iss. 2, pp. 216-229
Open Access | Times Cited: 159
Cancer situation in China: what does the China cancer map indicate from the first national death survey to the latest cancer registration?
Ruimei Feng, Su Qingling, Xiao‐Ying Huang, et al.
Cancer Communications (2022) Vol. 43, Iss. 1, pp. 75-86
Open Access | Times Cited: 79
Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region
Do Young Kim, Bao Nguyen Toan, Chee‐Kiat Tan, et al.
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 2, pp. 277-292
Open Access | Times Cited: 66
Diagnostic Accuracy of FibroScan and Factors Affecting Measurements
Satoshi Oeda, Kenichi Tanaka, Ayaka Oshima, et al.
Diagnostics (2020) Vol. 10, Iss. 11, pp. 940-940
Open Access | Times Cited: 78
Collagen Remodeling along Cancer Progression Providing a Novel Opportunity for Cancer Diagnosis and Treatment
Kena Song, Zhangqing Yu, Xiangyang Zu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10509-10509
Open Access | Times Cited: 49
FUT8 and Protein Core Fucosylation in Tumours: From Diagnosis to Treatment
Chengcheng Liao, Jiaxing An, Suqin Yi, et al.
Journal of Cancer (2021) Vol. 12, Iss. 13, pp. 4109-4120
Open Access | Times Cited: 52
FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic
Yoshio Sumida, Masashi Yoneda, Katsutoshi Tokushige, et al.
Life (2021) Vol. 11, Iss. 2, pp. 143-143
Open Access | Times Cited: 46
Biomarkers of Oncogenesis, Adipose Tissue Dysfunction and Systemic Inflammation for the Detection of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
Gian Paolo Caviglia, Angelo Armandi, Chiara Rosso, et al.
Cancers (2021) Vol. 13, Iss. 10, pp. 2305-2305
Open Access | Times Cited: 35
Incidence of hepatocellular carcinoma in nonalcoholic fatty liver disease without cirrhosis or advanced liver fibrosis
Jaideep Behari, Amir Gougol, Renwei Wang, et al.
Hepatology Communications (2023) Vol. 7, Iss. 7
Open Access | Times Cited: 16
Type IV Collagen 7S Is the Most Accurate Test For Identifying Advanced Fibrosis in NAFLD With Type 2 Diabetes
Hiroshi Ishiba, Yoshio Sumida, Yuya Seko, et al.
Hepatology Communications (2020) Vol. 5, Iss. 4, pp. 559-572
Open Access | Times Cited: 37
Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease
Karim Seif El Dahan, Darine Daher, Amit G. Singal
Clinical and Molecular Hepatology (2022) Vol. 29, Iss. Suppl, pp. S207-S219
Open Access | Times Cited: 21
Risk factors and diagnostic biomarkers for nonalcoholic fatty liver disease-associated hepatocellular carcinoma: Current evidence and future perspectives
Masayuki Ueno, Haruhiko Takeda, Atsushi Takai, et al.
World Journal of Gastroenterology (2022) Vol. 28, Iss. 27, pp. 3410-3421
Open Access | Times Cited: 17
The Implications of Noncoding RNAs in the Evolution and Progression of Nonalcoholic Fatty Liver Disease (NAFLD)-Related HCC
Ioana Rusu, Radu Pîrlog, Paul Chiroi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12370-12370
Open Access | Times Cited: 16
Diagnostic and prognostic performances of GALAD score in staging and 1-year mortality of hepatocellular carcinoma: A prospective study
Oraphan Jitpraphawan, Witchakorn Ruamtawee, Mala Treewatchareekorn, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 17, pp. 2343-2353
Open Access | Times Cited: 2
Diagnostic Performance of Extrahepatic Protein Induced by Vitamin K Absence in the Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
Mirela-Georgiana Perné, Adela Sitar-Tăut, Teodora Alexescu, et al.
Diagnostics (2023) Vol. 13, Iss. 5, pp. 816-816
Open Access | Times Cited: 6
An Overview of Hepatocellular Carcinoma Surveillance Focusing on Non-Cirrhotic NAFLD Patients: A Challenge for Physicians
Annalisa Cespiati, Felice Cinque, Marica Meroni, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 586-586
Open Access | Times Cited: 5
Evaluating M2BPGi as a Marker for Liver Fibrosis in Patients with Chronic Hepatitis B
Hoang Huu Bui, Suong Thi-Bang Nguyen, Sang The Phan, et al.
Digestive Diseases and Sciences (2023) Vol. 68, Iss. 12, pp. 4407-4417
Open Access | Times Cited: 5
<strong>Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease</strong>
Yoshio Sumida, Masashi Yoneda, Yuya Seko, et al.
(2020)
Open Access | Times Cited: 10
Current status of ultrasonography in national cancer surveillance program for hepatocellular carcinoma in South Korea: a large-scale multicenter study
Sun Hong Yoo, Soon Sun Kim, Sang Gyune Kim, et al.
Journal of Liver Cancer (2023) Vol. 23, Iss. 1, pp. 189-201
Open Access | Times Cited: 3
Cutoff values of protein induced by vitamin K absence or antagonist II for diagnosing hepatocellular carcinoma
Tyng‐Yuan Jang, Chia‐Yen Dai
Medicine (2022) Vol. 101, Iss. 39, pp. e30936-e30936
Open Access | Times Cited: 5
Utility of Mac-2 binding protein glycosylation isomer as an excellent biomarker for the prediction of liver fibrosis, activity, and hepatocellular carcinoma onset: an expert review
Yoshihiro Kamada, Yoshio Sumida, Hirokazu Takahashi, et al.
Journal of Gastroenterology (2024)
Closed Access
GALAD, or des-gamma-carboxy prothrombin compared with alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in people with chronic liver disease
Merica Aralica, Tin Nadarević, Agostino Colli, et al.
Cochrane library (2024) Vol. 2024, Iss. 12
Closed Access
Noninvasive tests predict liver‐related events and mortality in patients with nonalcoholic fatty liver disease: sub‐analysis of the CLIONE‐Asia study
Hiroshi Ishiba, Yoshio Sumida, Yoshihiro Kamada, et al.
Journal of Gastroenterology and Hepatology (2023) Vol. 38, Iss. 6, pp. 896-904
Closed Access | Times Cited: 1
Elevated Serum Alpha-fetoprotein Levels in Non-alcoholic Steatohepatitis: Possible Molecular Mechanisms and Potential Clinical Significance
Yurong Wang, Xianghua Cui, Haiying Zhang, et al.
Gene Expression (2023) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 1
The Usefulness of Vitamin K-Dependent Proteins in the Diagnosis of Colorectal Carcinoma
Mirela-Georgiana Perné, Adela Sitar-Tăut, Olga Orășan, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4997-4997
Open Access
Page 1 - Next Page

Scroll to top